Viewing nowCombinationEmpamax M Tablet 12.5/850 mg (Empagliflozin, Metformin)
Empagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang

MFDS item code 202107451 · Approved 2021.11.12 · Insurance code 643309930
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in adult patients with type 2 diabetes. It is particularly effective for patients whose blood sugar is not adequately controlled, and caution should be exercised if there are accompanying cardiovascular diseases in relation to relevant clinical information. When administered this way, it helps efficiently manage blood sugar levels while improving the overall health of the patient.
The recommended dose of this medicine is 1 tablet twice daily. Determine the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose in that case. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2)). Older adults In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication consists of two components that help control blood sugar. During the course of taking this medication, a rare side effect called severe lactic acidosis may occur, so caution should be exercised, especially in patients with poor kidney function or problems with the heart or liver. Additionally, when taken in conjunction with insulin or other diabetes medications, hypoglycemic symptoms may appear, so blood sugar levels should be checked frequently. Patients with moderate to severe renal impairment or acute kidney problems, heart failure, severe infections, or those scheduled for surgery should not take this medication and should discontinue it before and after examinations using iodine contrast agents. Pregnant or breastfeeding women and patients with liver dysfunction should also avoid this medication. While taking this medication, side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, gastrointestinal disturbances (nausea, vomiting, diarrhea), abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, erythema, increased serum lipids, increased serum creatinine, thirst, hyponatremia, weight gain or loss, headache, dizziness, insomnia, anxiety, chest discomfort, weakness, facial swelling, fever, and blood pressure issues may occur, and any abnormal symptoms should be reported to a physician immediately. Particularly, patients at risk for dehydration or fluid loss should carefully monitor blood pressure and fluid status, and temporarily discontinue the medication if necessary. This medication may decrease vitamin B12 levels, so regular blood tests should be conducted during long-term use. Alcohol consumption can increase the risk of lactic acidosis, so it is important not to drink excessively while taking this medication. Moreover, there are several medications that may interact with this medication, so if you are taking other medications, be sure to inform your healthcare provider or pharmacist. Elderly individuals are at a higher risk of declining kidney function and require dosage adjustments and regular monitoring of kidney function. Serious side effects may occur in case of overdose, so immediate medical treatment should be sought. Store this medication out of reach of children and keep it in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity, so it must be stored in a sealed container. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius to safely preserve the efficacy of the medication over time.
A white, oval-shaped, bidirectional convex film-coated tablet with a pink tinge.
60 tablets/box [10 tablets/Blister x 6], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 31.38mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.